{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T11:26:02Z","timestamp":1790853962517,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Sanofi Pasteur MSD"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.vaccine.2012.02.062","type":"journal-article","created":{"date-parts":[[2012,3,7]],"date-time":"2012-03-07T02:45:53Z","timestamp":1331088353000},"page":"3082-3089","source":"Crossref","is-referenced-by-count":24,"title":["Immunogenicity and safety of a two-dose regimen of a combined measles, mumps, rubella and varicella live vaccine (ProQuad\u00ae) in infants from 9 months of age"],"prefix":"10.1016","volume":"30","author":[{"given":"Timo","family":"Vesikari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Gajdos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Fiquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Baudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2012.02.062_bib0005","unstructured":"World Health Organization. Recommended Routine Immunization http:\/\/www.who.int\/immunization\/policy\/Immunization_routine_table1.pdf (updated June 9, 2010)."},{"key":"10.1016\/j.vaccine.2012.02.062_bib0010","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1097\/INF.0b013e31806211aa","article-title":"Distribution of serum measles-neutralizing antibodies according to age in women of childbearing age in France in 2005\u20132006: impact of routine immunization","volume":"26","author":"Pinquier","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2012.02.062_bib0015","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0022-3476(65)80112-3","article-title":"Studies on immunity to measles","volume":"66","author":"Krugman","year":"1965","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2012.02.062_bib0020","doi-asserted-by":"crossref","first-page":"c1626","DOI":"10.1136\/bmj.c1626","article-title":"Early waning of maternal measles antibodies in era of measles elimination: longitudinal study","volume":"340","author":"Leuridan","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2012.02.062_bib0025","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.1016\/j.vaccine.2006.01.026","article-title":"Seroprevalence of varicella-zoster virus IgG antibodies in Swiss children during the first 16 months of age","volume":"24","author":"Heininger","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.02.062_bib0030","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1017\/S0950268808001131","article-title":"Varicella paediatric hospitalizations in Spain","volume":"137","author":"Guill\u00e9n","year":"2009","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2012.02.062_bib0035","unstructured":"Health Protection Agency. Rubella notifications, by Age Group, 1989\u20132009. http:\/\/www.hpa.org.uk\/web\/HPAweb&HPAwebStandard\/HPAweb_C\/1195733842982 [accessed 22.11.10]."},{"key":"10.1016\/j.vaccine.2012.02.062_bib0040","unstructured":"Health Protection Agency. Mumps notifications, by Age Group, 1989\u20132009. http:\/\/www.hpa.org.uk\/web\/HPAweb&HPAwebStandard\/HPAweb_C\/1195733844620 [accessed 22.11.10]."},{"key":"10.1016\/j.vaccine.2012.02.062_bib0045","unstructured":"World Medical Organization. WMA Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects. [22.10.08]. Available at: http:\/\/www.wma.net\/en\/30publications\/10policies\/b3\/."},{"key":"10.1016\/j.vaccine.2012.02.062_bib0050","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/sim.4780040211","article-title":"Comparative analysis of two rates","volume":"4","author":"Miettinen","year":"1985","journal-title":"Stat Med"},{"key":"10.1016\/j.vaccine.2012.02.062_bib0055","series-title":"Modelling binary data","author":"Collett","year":"2003"},{"key":"10.1016\/j.vaccine.2012.02.062_bib0060","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I","article-title":"Interval estimation for the difference between independent proportions: comparison of eleven methods","volume":"17","author":"Newcombe","year":"1998","journal-title":"Stat Med"},{"key":"10.1016\/j.vaccine.2012.02.062_bib0065","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0022-3476(77)81021-4","article-title":"Persistence of maternal antibody in infants beyond 12 months: mechanism of measles vaccine failure","volume":"91","author":"Albrecht","year":"1977","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2012.02.062_bib0070","first-page":"315","article-title":"Inadequate immunity to measles in children vaccinated at an early age: effect of revaccination","volume":"62","author":"Black","year":"1984","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2012.02.062_bib0075","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/jmv.1890130111","article-title":"The use of IgM tests for analysis of the causes of measles vaccine failures: experience gained in an epidemic in Hungary in 1980 and 1981","volume":"13","author":"Nagy","year":"1984","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2012.02.062_bib0080","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1651-2227.2004.tb03055.x","article-title":"The genetic basis for measles vaccine failure","volume":"93","author":"Jacobson","year":"2004","journal-title":"Acta Paediatr Suppl"},{"key":"10.1016\/j.vaccine.2012.02.062_bib0085","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1097\/INF.0b013e318060d33d","article-title":"Immunogenicity of Oka\/Merck varicella vaccine in children vaccinated at 12\u201314 months of age versus 15\u201323 months of age","volume":"26","author":"Silber","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2012.02.062_bib0090","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S0140-6736(06)69561-5","article-title":"Varicella","volume":"368","author":"Heininger","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2012.02.062_bib0095","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1128\/CVI.00397-08","article-title":"Prevalence of anti-varicella-zoster virus antibodies in French infants under 15 months of age","volume":"16","author":"Pinquier","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2012.02.062_bib0100","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1002\/jmv.20754","article-title":"The optimization and validation of the glycoprotein ELISA assay for quantitative varicella-zoster virus (VZV) antibody detection","volume":"78","author":"Hammond","year":"2006","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2012.02.062_bib0105","series-title":"ProQuad summary of product characteristics","author":"Sanofi Pasteur","year":"2006"},{"key":"10.1016\/j.vaccine.2012.02.062_bib0110","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4161\/hv.2.5.3246","article-title":"Safety and immunogenicity of a combination measles, mumps, rubella and varicella vaccine (ProQuad)","volume":"2","author":"Kuter","year":"2006","journal-title":"Hum Vaccine"},{"key":"10.1016\/j.vaccine.2012.02.062_bib0115","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1016\/j.vaccine.2009.05.056","article-title":"Observational safety study of febrile convulsion following first dose MMRV vaccination in a managed care setting","volume":"27","author":"Jacobsen","year":"2009","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12002691?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12002691?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,25]],"date-time":"2018-11-25T08:20:14Z","timestamp":1543134014000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12002691"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":23,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0264410X12002691"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.02.062","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}